Clear Creek Financial Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $318K | Buy |
+606
| New | +$318K | 0.03% | 428 |
|
|
2023
Q2 | – | Sell |
-1,047
| Closed | -$860K | – | 339 |
|
|
2023
Q1 | $860K | Buy |
1,047
+57
| +6% | +$46.8K | 0.16% | 112 |
|
|
2022
Q4 | $714K | Buy |
990
+66
| +7% | +$47.6K | 0.16% | 122 |
|
|
2022
Q3 | $637K | Sell |
924
-7
| -0.8% | -$4.83K | 0.14% | 125 |
|
|
2022
Q2 | $550K | Buy |
931
+69
| +8% | +$40.8K | 0.12% | 146 |
|
|
2022
Q1 | $602K | Sell |
862
-59
| -6% | -$41.2K | 0.09% | 166 |
|
|
2021
Q4 | $582K | Sell |
921
-623
| -40% | -$394K | 0.09% | 173 |
|
|
2021
Q3 | $934K | Buy |
1,544
+363
| +31% | +$220K | 0.15% | 132 |
|
|
2021
Q2 | $660K | Buy |
+1,181
| New | +$660K | 0.1% | 160 |
|
|
2020
Q3 | – | Sell |
-583
| Closed | -$363K | – | 222 |
|
|
2020
Q2 | $363K | Buy |
+583
| New | +$363K | 0.09% | 155 |
|